Predictive value of serum levels of basic fibroblast growth factor, vascular endothelial growth factor and matrix metalloproteinase-2 in advanced carcinomas of the head and neck;Prognostische bedeutung von bFGF, VEGF und MMP-2 im serum von patienten mit fortgeschrittenen kopf-hals-tumoren

HNO

Volumn 47, Issue 8, 1999, Pages 695-701

  Dietz, A ^a   Rudat, V ^a   Vanselow, B ^a   Conradt, C ^a   Mohler T ^a  

^a NONE

Author keywords

Basic fibroblast growth factor; Head and neck cancer; Matrix metalloproteinase 2; Prognostic factors; Radiochemotherapy; Tumor angiogenesis; Vascular endothelial growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CARBOPLATIN; GELATINASE A; VASCULOTROPIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEAD AND NECK CARCINOMA; HUMAN; NEOVASCULARIZATION (PATHOLOGY); PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL;

ADULT; AGED; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LYMPHOKINES; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; OTORHINOLARYNGOLOGIC NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032834752     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001060050447     Document Type: Article

References (37)

1. Andl T, Kahn T, Pfuhl A et al. (1998) Etiological involvement of oncogenic human papillomavirus in tonsillar saquamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 58:5-13
2. Bramhall SR, Neoptolemos JP, Stamp GW, Lemoine NR (1997) Imbalance of expression of matrix metalloproteinase (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. J Pathol 182:347-355
3. Brattstrom D, Bergqvist M, Larsson A et al. (1998) Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients. Anticancer Res 18:1123-1128
4. Brawer MK, Jonsson E, Gibbons RP, Deering RE, Bigler SA, Preston SD (1994) Extent of prostate neovascularity predicts progression in patients with pathologic stage c adenocarcinoma treated with radical prostatectomy. J Urol 151:289
5. Brooks PC, Stromblad S, Klemke R, Vischer D, Sarkar FH, Cheresh DA (1995) Antiintegrin alpha-v-beta-3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 96:1815-1822
6. Brooks PC, Strömblad S, Sanders LC et al. (1996) Localization of matrix metalloproteinase MMP-2 to thesurface of invasive cells by interaction with integrin alpha-v-beta-3. Cell 85:683-693
7. Colomer R, Aparicio J, Montero S, Guzmán C, Larrodera L,Cortés-Funes (1997) Low levels of basic fibroblast growth factor (bFGF) are associated with poor prognosis in human breast carcinoma. Br J Cancer 76: 1215-1220
8. Dellacono FR, Spiro J, Eisma R, Kreutzer D (1997) Expression of basic fibroblast growth factor and ist receptors by head and neck squamous carcinoma tumor and vascular endothelial cells. Am J Surg 174: 540-544
9. Delorme S, Dietz A, Rudat V, Zuna I, Bahner ML, van Kaick G (1997) Prognostic significance of color doppler findings in head and neck tumors. Ultrasound Med Biol 23:1311-1317
10. Dirix LY, Vermeulen PB, Hubens G, Benoy I, Martin M, De Pooler C, Van Oosterom AT (1996) Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer. Ann Oncol 7:843-848
11. Erber R, Conradt C, Homann N et al. (1998) TPS3 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer. Oncogene 16:1671-1679
12. Hughes CJ, Reed JA, Cabal R, Huvos AG, Albino AP, Schantz SP (1994) Increased expression of basic fibroblast growth factor in squamous carcinogenesis of the head and neck is less prevalent following smoking cessation. Am J Surg 168:381-385
13. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1:27-31
14. Janot F, El-Naggar AK, Morrison RS, Liu TJ, Taylor DL, Clayman GL (1995) Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation. Int J Cancer 64:117-123
15. Kawamata H, Uchida D, Hamano H et al. (1998) Active-MMP2 in cancer cell nests of oral cancer patients: correlation with lymph node metastasis, Int J Oncol 13:699-704
16. Landriscina M, Casano A, Ratto C et al. (1998) Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer. Br J Cancer 78:765-770
17. Leunig A, Tauber S, Spaett R, Grevers G, Leunig M (1998) Basic fibroblast growth factor in serum and urine of patients with head and neck cancer. Oncol Rep 5:955-958
18. Mattern J, Koomagi R, Volm M (1996) Association of vascular growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br J Cancer 73:931-934
19. Meyer G, Yu E, Siegal J, Petteway J, Blumenstein B, Brawer M (1995) Serum basic fibroblast growth factor in men with and without prostate carcinoma. Cancer 76: 2304-2311
20. Mori M, Mimori K, Shiraishi T et al. (1997) Analysis of MT1-MMP and MMP2 expression in human gastric cancers. Int J Cancer 74: 316-321
21. Musso O, Theret N, Campion JP, Turlin B, Milani S, Grappone C, Clement B (1997) In situ detection of matrix metalloproteinase-2 (MMP2) and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma and in liver metastases. J Hepatol 26:593-605
22. Petruzzelli GJ, Benefield J, Taitz AD et al. (1997) Heparin-binding growth factors(s) derived from head and neck sqouamous cell carcinomas induce endothelial cell proliferations. Head Neck 19:576-582
23. Risau W (1997) Mechanisms of angiogenesis. Nature 386:671-674
24. Rudat V, Dietz A, Schramm O, Maier H, Flentje M, Wannenmacher M (1999) Simultaneous accelerated radiochemotherapy with carboplatin in advanced head and neck cancer patients: prognostic factors and toxicity determined in a prospective study. Radiother Oncol (accepted for publication)
25. Salven P, Heikkila P, Anttonen A, Kajanti M, Joensuu H (1997) Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Mod Pathol 10:1128-1133
26. Salven P, Manpaa H, Orpana A, Alitalo K, Joensuu H (1997) Serum vascular endothelial growth factor is often elevated in disseminated cancer. Clin Cancer Res 3: 647-651
27. Schultz-Hector S, Haghayegh S (1993) Beta-fibroblast growth factor expression in human and murine squamous cell carcinomas and ist relationship to regional endothelial cell proliferation. Cancer Res 53: 1444-1449
28. Skobe M, Rockwell P, Goldstein N, Vossler S, Fusenig NE (1997) Halting angiogenesis suppresses carcinoma cell invasion. Nature Med 3:1222-1227
29. Sliutz G, Tempfer C, Obermair A, Reinthaller A, Gitsch G, Keinz C (1995) Serum evaluation of basic fibroblast growth factor in cervical cancer patients. Cancer Lett 94:227-231
30. Sliutz G, Tempfer C, Obermair A, Dadak C, Kainz C (1995) Serum evaluation of basic FGF in breast cancer patients. Anticancer Res 15:2675-2678
31. Srivatstava A, Laidler P, Davies R, Horgan K, Highes L (1988) The prognostic significance of tumor vascularity in intermediate thickness (0,76-4,0 mm thick) skin melanoma. Am J Pathol 133:419-423
32. Wang H, Rubin M, Fenig E, DeBlasio A, Mendelsohn J, Yahalom J, Wieder R (1997) Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events. Cancer Res 57: 1750-1757
33. Wenz F, Lohr F, Flentje M, Rudat V, Dietz A, Wannenmacher M (1997) Predictive value of the flow cytometric PCNA assay (proliferating cell nuclear antigen) in head and neck tumors after accelerated hyperfractionated radiochemotherapy. Int J Radiat Oncol Biol Phys 37:771-776
34. Yamamoto Y, Toi M, Kondo S et al. (1996) Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Cancer Res 2: 821-826
35. Yamazaki K, Abe S, Takekawa H et al. (1994) Tumor angiogenesis in human lung adenocarcinoma. Cancer 74:2245-2250
36. Zatterstrom UK, Brun E, Willen R, Kjellen E, Wenneberg J (1995) Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head Neck 17: 312-318
37. Zmering MB, Brandhi ML, DeGrange DA et al. (1990) Circulating fibroblast growth factor-like substance in familial multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 70:149-154